Sign in

CIK 0000879407

  • Large accelerated filer

ARROWHEAD PHARMACEUTICALS, INC.

Sign in to watch
Ticker
ARWR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Sep 30
Incorporated
DE
Entity type
Operating
EIN
460408024
Phone
+1 626-696-4702
Business address
177 E COLORADO BLVD, SUITE 700, PASADENA, CA, 91105
Former names
ARROWHEAD RESEARCH CORP, INTERACTIVE GROUP INC, INTERACTIVE INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2025-12-15 Anzalone Christopher Richard Chief Executive Officer Sale −21,321 $69.28 $1.5M 3,979,402
2025-12-15 Anzalone Christopher Richard Chief Executive Officer Sale −8,147 $69.96 $570K 3,971,255
2025-12-05 PERRY MICHAEL S Director Sale −16,250 $61.03 $992K 115,240
2025-11-28 Ferrari Mauro Director Sale −8,750 $56.39 $493K 68,764
2025-10-01 Hamilton James C Chief Medical Officer Sale 10b5-1 −20,000 $35.00 $700K 212,122
2025-09-12 Hamilton James C Chief Medical Officer Sale 10b5-1 −15,000 $30.00 $450K 232,122
2025-09-02 Hamilton James C Chief Medical Officer Sale 10b5-1 −15,000 $25.00 $375K 247,122
2025-08-15 Hamilton James C Chief Medical Officer Sale 10b5-1 −9,389 $20.00 $188K 262,122
2025-08-13 Hamilton James C Chief Medical Officer Sale 10b5-1 −611 $20.00 $12K 271,511
2025-04-11 Anzalone Christopher Richard Chief Executive Officer Sale −50,800 $11.49 $584K 3,921,255
2025-04-10 Anzalone Christopher Richard Chief Executive Officer Sale −50,000 $10.87 $544K 3,972,055
2025-04-09 Anzalone Christopher Richard Chief Executive Officer Sale −35,305 $9.93 $351K 4,027,072
2025-04-09 Anzalone Christopher Richard Chief Executive Officer Sale −3,400 $10.75 $37K 4,023,672
2025-04-09 Anzalone Christopher Richard Chief Executive Officer Sale −1,617 $11.76 $19K 4,022,055
2025-03-13 Anzalone Christopher Richard Chief Executive Officer Sale −51,425 $15.07 $775K 4,062,377
2025-03-04 Anzalone Christopher Richard Chief Executive Officer Sale 10b5-1 −133,333 $17.02 $2.3M 3,773,802
2025-03-03 Anzalone Christopher Richard Chief Executive Officer Sale 10b5-1 −166,667 $18.03 $3.0M 3,907,135
2025-01-23 OLUKOTUN ADEOYE Y Director Sale 10b5-1 −959 $21.00 $20K 35,781
2025-01-07 O'Brien Patrick COO and General Counsel Sale 10b5-1 −8,000 $19.69 $158K 527,201
2025-01-07 Myszkowski Kenneth Allen Chief Financial Officer Sale 10b5-1 −8,000 $19.70 $158K 465,433

Page 4 of 23 · 444 trades